Background
Background Improved management Improved management of mental illness and substance misuse of mental illness and substance misuse comorbidity is a National Health Service comorbidity is a National Health Service priority, but little is known about its priority, but little is known about its prevalence and current management. prevalence and current management.
Aims
Aims To measure the prevalence of To measure the prevalence of comorbidity among patients of community comorbidity among patients ofcommunity mental health teams (CMHTs) and mental health teams (CMHTs) and substance misuse services, and to assess substance misuse services, and to assess the potential for joint management. the potential for joint management.
Method Method Cross-sectional prevalence
Cross-sectional prevalence survey in four urban UK centres. survey in four urban UK centres.
Results
Results Of CMHT patients, 44% (95% Of CMHT patients, 44% (95% CI 38.1^49.9) reported past-year problem CI 38.1^49.9) reported past-year problem drug use and/or harmful alcohol use; 75% drug use and/or harmful alcohol use; 75% (95% CI 68.2^80.2) of drug service and (95% CI 68.2^80.2) of drug service and 85% of alcohol service patients (95% CI 85% of alcohol service patients (95% CI 74.2^93.1) had a past-year psychiatric 74.2^93.1) had a past-year psychiatric disorder.Most comorbidity patients disorder.Most comorbidity patients appear ineligible for cross-referral appear ineligible for cross-referral between services.Large proportions are between services.Large proportions are not identified by services and receive no not identified by services and receive no specialist intervention. specialist intervention.
Conclusions Conclusions Comorbidity is highly
Comorbidity is highly prevalent in CMHT, drug and alcohol prevalent in CMHT, drug and alcohol treatment populations, but may be treatment populations, but may be difficultto manage by cross-referral difficultto manage by cross-referral psychiatric and substance misuse services psychiatric and substance misuse services as currently configured and resourced. as currently configured and resourced.
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Comorbidity of mental illness and Comorbidity of mental illness and substance misuse (comorbidity) has been substance misuse (comorbidity) has been associated with increased psychiatric associated with increased psychiatric admission (Hunt admission (Hunt et al et al, 2002 (Hunt et al et al, ), violence , 2002 , violence (Scott (Scott et al et al, 1998) , suicidal behaviour , 1998), suicidal behaviour (Appleby (Appleby et al et al, 1999) , excess service costs , 1999), excess service costs (Hoff & Rosenheck, 1999) and poor treat- (Hoff & Rosenheck, 1999) and poor treatment outcome in both psychiatric (Hunt ment outcome in both psychiatric (Hunt et et al al, 2002) and substance misuse treatment , 2002) and substance misuse treatment populations (Carey populations (Carey et al et al, 1991) . Improved , 1991) . Improved management of comorbidity is now a prior-management of comorbidity is now a priority of the National Health Service (NHS) in ity of the National Health Service (NHS) in the UK (Banerjee the UK (Banerjee et al et al, 2002) and options , 2002) and options for service development have been widely for service development have been widely discussed (Hall & Farrell, 1997; Johnson, discussed (Hall & Farrell, 1997; Johnson, 1997; Weaver 1997; Weaver et al et al, 1999) . However, the , 1999). However, the absence of comparable multi-centre absence of comparable multi-centre prevalence data from UK substance misuse prevalence data from UK substance misuse and community mental health team and community mental health team (CMHT) treatment populations, and (CMHT) treatment populations, and limited evidence about the current capacity limited evidence about the current capacity of these services to manage comorbidity, of these services to manage comorbidity, has hampered the identification of has hampered the identification of appropriate service delivery models. appropriate service delivery models.
METHOD METHOD

Study aims Study aims
Our study aims were to measure the preva-Our study aims were to measure the prevalence of comorbidity among patients of lence of comorbidity among patients of CMHTs and substance misuse services in CMHTs and substance misuse services in four inner-city treatment centres, to assess four inner-city treatment centres, to assess whether there were differences in the preva-whether there were differences in the prevalence between centres, and to measure the lence between centres, and to measure the potential for joint management by CMHT potential for joint management by CMHT and substance misuse services where and substance misuse services where patients with comorbidity were identified. patients with comorbidity were identified.
Design and setting Design and setting
We conducted a cross-sectional prevalence We conducted a cross-sectional prevalence survey between January 2001 and February survey between January 2001 and February 2002 in four urban UK centres. These were 2002 in four urban UK centres. These were two neighbouring inner-London boroughs two neighbouring inner-London boroughs (Brent, and Hammersmith and Fulham) and (Brent, and Hammersmith and Fulham) and services in inner-city areas of Nottingham services in inner-city areas of Nottingham and Sheffield. At all four centres the CMHTs and Sheffield. At all four centres the CMHTs were consultant-led, multi-disciplinary were consultant-led, multi-disciplinary teams serving geographically defined catch-teams serving geographically defined catchment areas. Each had access to designated ment areas. Each had access to designated in-patient beds, operated in-patient beds, operated according to according to contemporary care programme contemporary care programme approach approach (CPA) guidelines and gave priority (in terms (CPA) guidelines and gave priority (in terms of the allocation of case-load places) to of the allocation of case-load places) to patients with severe and enduring mental patients with severe and enduring mental illness. The drug and alcohol teams were illness. The drug and alcohol teams were statutory providers. They offered separate statutory providers. They offered separate structured, appointment-based services structured, appointment-based services through keyworkers within nurse-led through keyworkers within nurse-led clinics. All clients were allocated a personal clinics. All clients were allocated a personal keyworker and assigned to the case-load of keyworker and assigned to the case-load of a psychiatrist or responsible medical officer a psychiatrist or responsible medical officer (RMO). All drug services had a strong (RMO). All drug services had a strong emphasis upon the management of opiate emphasis upon the management of opiate dependency. Independent drug services dependency. Independent drug services were available in some areas (including were available in some areas (including services for stimulant users), but not in services for stimulant users), but not in others. These latter agencies were not inves-others. These latter agencies were not investigated. In each population, we completed a tigated. In each population, we completed a case-load census to identify the sampling case-load census to identify the sampling frame and a patient interview survey with frame and a patient interview survey with case-note audit in a random sample. case-note audit in a random sample.
Participants Participants
All patients of the drug and alcohol teams All patients of the drug and alcohol teams who were allocated to the case-load of a who were allocated to the case-load of a keyworker and psychiatrist/RMO on the keyworker and psychiatrist/RMO on the census date were included in the substance census date were included in the substance misuse case-load census population. The misuse case-load census population. The only current patients excluded were a small only current patients excluded were a small proportion who had not completed an proportion who had not completed an assessment. The sample sizes were propor-assessment. The sample sizes were proportionate to the size of the total treatment tionate to the size of the total treatment populations in each centre. To be included populations in each centre. To be included in the CMHT case-load census population, in the CMHT case-load census population, patients had to be allocated to the case-load patients had to be allocated to the case-load of a care coordinator and psychiatrist/ of a care coordinator and psychiatrist/ RMO on the census date, be aged 16-64 RMO on the census date, be aged 16-64 years and be included on the local CPA years and be included on the local CPA register. Only a small proportion of current register. Only a small proportion of current CMHT patients were excluded because CMHT patients were excluded because they had not completed an assessment, or they had not completed an assessment, or exceeded the age range. Interview samples exceeded the age range. Interview samples of 400 CMHT and 353 substance misuse of 400 CMHT and 353 substance misuse patients were selected from these census patients were selected from these census populations at the coordinating centre populations at the coordinating centre (Imperial College) using Statistical Package (Imperial College) using Statistical Package for the Social Sciences (SPSS) random case for the Social Sciences (SPSS) random case selection procedures (SPSS, 1999) . selection procedures (SPSS, 1999) .
Data collection Data collection
Data collection procedures were agreed Data collection procedures were agreed with local research ethics committees. with local research ethics committees. Services identified eligible patients, who Services identified eligible patients, who were allocated anonymous case numbers were allocated anonymous case numbers used in all data collection. Care co-used in all data collection. Care coordinators and keyworkers completed ordinators and keyworkers completed census questionnaires (one per patient), census questionnaires (one per patient), gave patients sampled for interview an gave patients sampled for interview an information sheet, and invited them to meet information sheet, and invited them to meet a trained fieldworker. All interviewed a trained fieldworker. All interviewed patients gave written informed consent. patients gave written informed consent. Non-consenting patients were regarded as Non-consenting patients were regarded as non-respondents and not substituted. non-respondents and not substituted.
Assessments Assessments
Case-load census Case-load census
Care coordinators and keyworkers were Care coordinators and keyworkers were asked to report demographic details, ICD-asked to report demographic details, ICD-10 psychiatric diagnoses (World Health 10 psychiatric diagnoses (World Health Organization, 1992) established or con-Organization, 1992) established or confirmed by psychiatric assessment in the past firmed by psychiatric assessment in the past year, and any psychiatric and substance year, and any psychiatric and substance misuse interventions provided in the past misuse interventions provided in the past month. Care coordinators for CMHT month. Care coordinators for CMHT patients were asked to identify people using patients were asked to identify people using any illicit or non-prescribed drug in the past any illicit or non-prescribed drug in the past year, and to apply diagnostic criteria year, and to apply diagnostic criteria (reproduced on the census form) to this (reproduced on the census form) to this group to identify those misusing drugs group to identify those misusing drugs (American Psychiatric Association, 1994) . (American Psychiatric Association, 1994) . Care coordinators applied the same criteria Care coordinators applied the same criteria to all patients to identify those misusing to all patients to identify those misusing alcohol. alcohol.
Interview survey Interview survey
Mental health status was assessed using the Mental health status was assessed using the Quick Personality Assessment Schedule Quick Personality Assessment Schedule (Tyrer, 2000) , the Comprehensive Psycho- (Tyrer, 2000) , , 1991 ) based on a case-note review. A 1991) based on a case-note review. A specificity analysis was completed using specificity analysis was completed using information from the patient interview to information from the patient interview to ensure conservative rating of psychosis. ensure conservative rating of psychosis.
We used service-defined diagnoses to We used service-defined diagnoses to identify CMHT patients with psychosis. identify CMHT patients with psychosis. We completed OPCRIT assessments in a We completed OPCRIT assessments in a subsample of cases, enabling a specificity subsample of cases, enabling a specificity analysis to be completed; this showed that analysis to be completed; this showed that service-defined diagnosis was acceptable service-defined diagnosis was acceptable and reliable in identifying people with and reliable in identifying people with psychotic disorders (sensitivity 95%, speci-psychotic disorders (sensitivity 95%, specificity 81%). In our analysis the diagnostic ficity 81%). In our analysis the diagnostic category 'psychosis' included schizophrenia category 'psychosis' included schizophrenia (F20.0-F20.9); schizotypal, schizoaffective, (F20.0-F20.9); schizotypal, schizoaffective, delusional and other unspecified psychotic delusional and other unspecified psychotic disorders (F21-F29); manic episode with disorders (F21-F29); manic episode with psychotic symptoms (F30.2); bipolar affec-psychotic symptoms (F30.2); bipolar affective disorder (F31); severe depression with tive disorder (F31); severe depression with psychotic disorder (F32.3); and recurrent psychotic disorder (F32.3); and recurrent severe depression with psychotic symptoms severe depression with psychotic symptoms (F33.3). The Alcohol Use Disorders (F33.3). The Alcohol Use Disorders Identification Test (AUDIT; Saunders Identification Test (AUDIT; Saunders et al et al, , 1993) identified harmful (score 1993) identified harmful (score 5 58) 8) and severe (score and severe (score 5 515) alcohol-related 15) alcohol-related problems. A structured interview checklist problems. A structured interview checklist identified drug types used (ever, past year, identified drug types used (ever, past year, past month) and whether associated past month) and whether associated problems were present (economic, domes-problems were present (economic, domestic, social, legal or interpersonal). Problem tic, social, legal or interpersonal). Problem drug use was defined as self-reported drug use was defined as self-reported presence of one or more of the above presence of one or more of the above drug-related problems or care coordinator drug-related problems or care coordinator assessment of misuse. The Severity of assessment of misuse. The Severity of Dependence Scale (Gossop Dependence Scale (Gossop et al et al, 1995) , 1995) assessed drug dependency. These assess-assessed drug dependency. These assessments were implemented in each treatment ments were implemented in each treatment population. population.
To assess the reliability of self-reported To assess the reliability of self-reported drug use in CMHT patients we tested drug use in CMHT patients we tested hair and urine samples, obtained from a hair and urine samples, obtained from a random subsample of participants, by random subsample of participants, by means of chromatography (Paterson means of chromatography (Paterson et al et al, , 2000) and mass spectrometry analysis 2000) and mass spectrometry analysis (Paterson (Paterson et al et al, 2001) . Samples were ob-, 2001). Samples were obtained contemporaneously with self-report tained contemporaneously with self-report data. However, consent for hair and urine data. However, consent for hair and urine testing was obtained separately after each testing was obtained separately after each interview assessment. interview assessment.
Analysis Analysis
All analysis presented in this paper was All analysis presented in this paper was undertaken with the interview samples undertaken with the interview samples achieved in each treatment population achieved in each treatment population (Fig. 1 ). The primary analysis calculated (Fig. 1) . The primary analysis calculated the proportions of each sample with co-the proportions of each sample with comorbid conditions and the size of sub-morbid conditions and the size of subpopulations defined in terms of psychiatric populations defined in terms of psychiatric diagnosis and pattern of substance misuse. diagnosis and pattern of substance misuse. We then measured the proportions of co-We then measured the proportions of comorbid cases that had been identified by morbid cases that had been identified by keyworkers. By measuring the severity and keyworkers. By measuring the severity and types of comorbid disorder we identified types of comorbid disorder we identified approximate thresholds for access to each approximate thresholds for access to each service. We used these data to assess the service. We used these data to assess the proportions of each treatment population proportions of each treatment population with high or low potential for cross-referral with high or low potential for cross-referral and who had documented contact with and who had documented contact with both psychiatric and substance misuse both psychiatric and substance misuse services. All prevalence estimates are services. All prevalence estimates are reported with exact binomial 95% confi-reported with exact binomial 95% confidence intervals. The statistical significance dence intervals. The statistical significance of observed differences in proportions was of observed differences in proportions was assessed using Pearson chi-squared or assessed using Pearson chi-squared or Fisher's exact tests. These analyses were Fisher's exact tests. These analyses were completed using SPSS (SPSS, 1999) . completed using SPSS (SPSS, 1999) .
We then completed an extended quanti-We then completed an extended quantitative analysis in relation to comorbid tative analysis in relation to comorbid and non-comorbid sample groups in each and non-comorbid sample groups in each treatment population. Multiple logistic treatment population. Multiple logistic regression was undertaken using cases with regression was undertaken using cases with complete data on age, gender, ethnicity and complete data on age, gender, ethnicity and diagnosis to investigate factors inde-diagnosis to investigate factors independently associated with comorbidity in pendently associated with comorbidity in the London centres the London centres v v. the aggregated . the aggregated Nottingham and Sheffield centres. Adjusted Nottingham and Sheffield centres. Adjusted odds ratios with 95% confidence intervals odds ratios with 95% confidence intervals were obtained and compared with the odds were obtained and compared with the odds ratios from the univariate analysis. All vari-ratios from the univariate analysis. All variables were entered as categorical variables. ables were entered as categorical variables. Interactions between age group, gender, Interactions between age group, gender, ethnicity, case-mix variables and location ethnicity, case-mix variables and location were investigated. The coding for ethnicity were investigated. The coding for ethnicity and age group was predetermined. The and age group was predetermined. The statistical package Stata 6.0 (StataCorp, statistical package Stata 6.0 (StataCorp, 1999) was used for these latter analyses. 1999) was used for these latter analyses.
RESULTS
Number and characteristics Number and characteristics of participants of participants
We obtained data on 2528 of 2567 CMHT We obtained data on 2528 of 2567 CMHT patients (98.5%) meeting census eligibility patients (98.5%) meeting census eligibility criteria ( Fig. 1 ). Interviews were completed criteria ( Fig. 1 ). Interviews were completed in 282 of 400 cases (70.5%) randomly in 282 of 400 cases (70.5%) randomly sampled from this population. Sixty-eight sampled from this population. Sixty-eight of the patients interviewed were randomly of the patients interviewed were randomly pre-sampled for subsequent hair and urine pre-sampled for subsequent hair and urine testing, and 50 provided a sample testing, and 50 provided a sample (73.5%). Keyworkers provided data about (73.5%). Keyworkers provided data about 1645 of 1674 substance misuse service 1645 of 1674 substance misuse service patients (98.3%) meeting census eligibility patients (98.3%) meeting census eligibility criteria. Complete interview and case-note criteria. Complete interview and case-note data were obtained in 278 of 353 randomly data were obtained in 278 of 353 randomly selected cases (78.8%) (216 drug service selected cases (78.8%) (216 drug service patients, 62 alcohol service patients). patients, 62 alcohol service patients).
Treatment populations were predomi-Treatment populations were predominantly male (57-67%). Men in contact nantly male (57-67%). Men in contact with drug services and CMHTs had similar with drug services and CMHTs had similar median ages (35 years and 36 years respec-median ages (35 years and 36 years respectively) and age group distributions. Patients tively) and age group distributions. Patients misusing alcohol were typically older misusing alcohol were typically older (median age 42 years). In contrast, women (median age 42 years). In contrast, women in contact with drug services had a younger in contact with drug services had a younger median age (32 years) than women in median age (32 years) than women in contact with alcohol services (39 years) or contact with alcohol services (39 years) or CMHTs (43 years). There were marked CMHTs (43 years). There were marked differences in ethnicity between patients differences in ethnicity between patients comprising the drug and alcohol case-loads comprising the drug and alcohol case-loads ( (4 490% White) and those of CMHTs 90% White) and those of CMHTs (68.8% White, 23.8% Black). (68.8% White, 23.8% Black).
Of the CMHT sample, three-quarters Of the CMHT sample, three-quarters ( (n n¼216) had a psychotic disorder and 41 216) had a psychotic disorder and 41 had a primary diagnosis of severe depres-had a primary diagnosis of severe depression. Additional 'complex care needs', sion. Additional 'complex care needs', which tend to qualify patients for enhanced which tend to qualify patients for enhanced CPA management, were present in 80% CPA management, were present in 80% ( (n n¼226): these were previous psychiatric 226): these were previous psychiatric admission, suicidal behaviour, self-neglect/ admission, suicidal behaviour, self-neglect/ harm, risk of exploitation or secondary harm, risk of exploitation or secondary psychiatric disorder. Most of the drug psychiatric disorder. Most of the drug service patients reported lifetime opiate service patients reported lifetime opiate use (92.6%, use (92.6%, n n¼200), and 78% ( 200), and 78% (n n¼158) 158) reported lifetime injected drug use. Some reported lifetime injected drug use. Some alcohol service patients reported controlled alcohol service patients reported controlled drinking in the past year, but 79% ( drinking in the past year, but 79% (n n¼49) 49) recorded AUDIT scores indicative of severe recorded AUDIT scores indicative of severe alcohol misuse. alcohol misuse.
Prevalence of comorbidity Prevalence of comorbidity in CMHT patients in CMHT patients
Among CMHT patients, 124 (44%) self-Among CMHT patients, 124 (44%) selfreported drug use and/or harmful alcohol reported drug use and/or harmful alcohol use (Table 1) . Harmful alcohol use (defined use ( Table 1) . Harmful alcohol use (defined by the AUDIT criteria) was reported by by the AUDIT criteria) was reported by about a quarter of patients ( about a quarter of patients (n n¼72) and 72) and about a tenth ( about a tenth (n n¼26) reported severe alco-26) reported severe alcohol misuse. Illicit or non-prescribed drug hol misuse. Illicit or non-prescribed drug use in the past year was reported by 87 use in the past year was reported by 87 (30.9%) patients; most met our criteria (30.9%) patients; most met our criteria for problem drug use: for problem drug use: n n¼64 (29.8%). Drug 64 (29.8%). Drug dependency was identified in 47 (16.7%). dependency was identified in 47 (16.7%). The most frequently reported drugs were The most frequently reported drugs were cannabis (25.2%, cannabis (25.2%, n n¼71), sedatives/ 71), sedatives/ tranquillisers (7.4%, tranquillisers (7.4%, n n¼21) and crack 21) and crack cocaine (5.7%, cocaine (5.7%, n n¼16). Heroin, ecstasy 16). Heroin, ecstasy (3,4-methylenedioxymethamphetamine) , (3,4-methylenedioxymethamphetamine) , amphetamines and cocaine powder were all amphetamines and cocaine powder were all reported by less than 4% (Table 1) . Harm-reported by less than 4% (Table 1) . Harmful alcohol use was strongly associated with ful alcohol use was strongly associated with problem drug use. Of the patients who did problem drug use. Of the patients who did not report drug use, 19% had harmful not report drug use, 19% had harmful levels of alcohol use. The prevalence of levels of alcohol use. The prevalence of harmful alcohol use was double this rate harmful alcohol use was double this rate in patients reporting any problem drug in patients reporting any problem drug use: 40.2% ( use: 40.2% (w w 2 2 ¼13.7, d.f. 13.7, d.f.¼1, 1, P P5 50.001). 0.001). Table 2 presents the findings of the Table 2 presents the findings of the comparison between self-reported 'past-comparison between self-reported 'pastmonth' drug use and the hair and urine month' drug use and the hair and urine analysis. This shows that virtually no un-analysis. This shows that virtually no unreported drug use was detected by hair reported drug use was detected by hair and urine analysis. Although 18 respon-and urine analysis. Although 18 respondents refused to provide samples, 4 of these dents refused to provide samples, 4 of these reported drug use and there was no case in reported drug use and there was no case in which care coordinators reported drug use which care coordinators reported drug use that the patient denied. that the patient denied.
Prevalence of comorbidity in drug Prevalence of comorbidity in drug and alcohol services and alcohol services Three-quarters of drug service patients Three-quarters of drug service patients ( (n n¼161) rated positive for at least one 161) rated positive for at least one psychiatric disorder (Table 3) . A psychotic psychiatric disorder (Table 3) . A psychotic disorder was present in 17 patients (8%), disorder was present in 17 patients (8%), personality disorder in 80 (37%) and severe personality disorder in 80 (37%) and severe depression in 58 (27%). The prevalence of depression in 58 (27%). The prevalence of all psychiatric disorders was markedly all psychiatric disorders was markedly higher among alcohol service patients, higher among alcohol service patients, although the small sample size means that although the small sample size means that the 95% confidence intervals for prevalence the 95% confidence intervals for prevalence estimates are wide ( Table 3) . estimates are wide ( Table 3) . Table 4 shows that a significantly higher Table 4 shows that a significantly higher proportion of CMHT patients from proportion of CMHT patients from London centres reported problem drug use London centres reported problem drug use than those from Nottingham and Sheffield than those from Nottingham and Sheffield (42% (42% v. v. 21, 21, w w 2 2 ¼13.9, d.f. 13.9, d.f.¼1, 1, P P5 50.001). 0.001). Patients reporting problem drug use in Patients reporting problem drug use in London centres ( London centres (n n¼48) also reported past-48) also reported pastyear use of a higher number of drug types year use of a higher number of drug types (mean (mean¼2.38) than drug-using patients in 2.38) than drug-using patients in Nottingham and Sheffield ( Nottingham and Sheffield (n n¼36; mean 36; mean¼ 1.65). Cannabis, sedatives/tranquillisers 1.65). Cannabis, sedatives/tranquillisers and crack cocaine use were all reported by and crack cocaine use were all reported by a significantly higher proportion of patients a significantly higher proportion of patients in London centres than in Nottingham and in London centres than in Nottingham and Sheffield. The prevalence of any drug Sheffield. The prevalence of any drug dependency was also significantly higher dependency was also significantly higher in patients from the London centres (25% in patients from the London centres (25% v. v. 11; 11; w w 2 2 ¼8.6, d.f. 8.6, d.f.¼1, 1, P P¼0.005). 0.005). Overall, there was a marked and statisti-Overall, there was a marked and statistically significant difference in proportions of cally significant difference in proportions of patients reporting problem drug use and/or patients reporting problem drug use and/or harmful alcohol use between London harmful alcohol use between London centres and Nottingham/Sheffield. This centres and Nottingham/Sheffield. This difference was mainly attributable to the difference was mainly attributable to the higher reported prevalence of problem drug higher reported prevalence of problem drug use in London, as there was no significant use in London, as there was no significant difference in the prevalence of harmful difference in the prevalence of harmful alcohol use between London centres and alcohol use between London centres and Nottingham/Sheffield. Nottingham/Sheffield.
Comparison of prevalence rates Comparison of prevalence rates between centres between centres CMHT populations CMHT populations
We completed an extended multivariate We completed an extended multivariate analysis to investigate whether the observed analysis to investigate whether the observed differences in prevalence of drug use differences in prevalence of drug use was explicable in terms of demographic was explicable in terms of demographic 3 0 6 3 0 6 We repeated this analysis to assess the We repeated this analysis to assess the association between reported harmful association between reported harmful alcohol use in the past year using the same alcohol use in the past year using the same demographic (gender, ethnicity, age) and demographic (gender, ethnicity, age) and psychiatric case-mix variables but sub-psychiatric case-mix variables but substituting 'presence of drug use' for 'presence stituting 'presence of drug use' for 'presence of harmful alcohol use'. The univariate of harmful alcohol use'. The univariate odds ratio of harmful alcohol use for odds ratio of harmful alcohol use for London CMHT patients was 1.18 London CMHT patients was 1.18 compared with Nottingham and Sheffield compared with Nottingham and Sheffield (95% CI 0.68-2.04). However, as indicated (95% CI 0.68-2.04). However, as indicated by the confidence interval, the difference in by the confidence interval, the difference in odds is not statistically significant. When odds is not statistically significant. When the above variables are included in the the above variables are included in the multiple regression model the adjusted odds multiple regression model the adjusted odds ratio of alcohol misuse in London centres ratio of alcohol misuse in London centres over Nottingham and Sheffield is reduced over Nottingham and Sheffield is reduced to a marginal level (AOR to a marginal level (AOR¼1.05, 95% CI 1.05, 95% CI 0.52-2.11). Hence, this series of adjusted 0.52-2.11). Hence, this series of adjusted analyses showed statistically significant analyses showed statistically significant difference in prevalence of drug use difference in prevalence of drug use between centres after adjustment for the between centres after adjustment for the selected case-mix variables. This contri-selected case-mix variables. This contributes to a statistically significant difference butes to a statistically significant difference in comorbidity (problem drug and/or harm-in comorbidity (problem drug and/or harmful alcohol use). However, there is no ful alcohol use). However, there is no evidence of a difference in the prevalence evidence of a difference in the prevalence of harmful alcohol use between centres. of harmful alcohol use between centres. Table 4 compares the observed prevalence Table 4 compares the observed prevalence rates of psychiatric disorder in drug service rates of psychiatric disorder in drug service patients between London centres and patients between London centres and Nottingham/Sheffield. Despite a consistent Nottingham/Sheffield. Despite a consistent pattern of marginally higher prevalence in pattern of marginally higher prevalence in London centres across the spectrum of dis-London centres across the spectrum of disorders, there is no statistically significant orders, there is no statistically significant difference in the proportions assessed to difference in the proportions assessed to have one or more disorder, or a disorder have one or more disorder, or a disorder within any of the three main subgroups within any of the three main subgroups assessed (psychosis, personality disorder, assessed (psychosis, personality disorder, affective and anxiety disorder). We imple-affective and anxiety disorder). We implemented an extended multivariate analysis mented an extended multivariate analysis to assess whether there was any difference to assess whether there was any difference in the odds of comorbidity between the in the odds of comorbidity between the London and Nottingham/Sheffield samples London and Nottingham/Sheffield samples after adjustment for demographic (gender, after adjustment for demographic (gender, ethnicity, age) and case-mix (presence of ethnicity, age) and case-mix (presence of alcohol misuse, drug use profile) variables. alcohol misuse, drug use profile) variables.
Drug and alcohol services Drug and alcohol services
This analysis revealed that the uni-This analysis revealed that the univariate odds ratio of any psychiatric variate odds ratio of any psychiatric disorder for patients on a London service disorder for patients on a London service case-load was 1.47 (95% CI 0.77-2.80) case-load was 1.47 (95% CI 0.77-2.80) 3 0 7 3 0 7 Potential for cross-referral Potential for cross-referral of patients of patients
CMHT patients CMHT patients
Just six of the CMHT patients were opiate-Just six of the CMHT patients were opiatedependent and had a high referral potential dependent and had a high referral potential for statutory opiate-based drug treatment for statutory opiate-based drug treatment services. An additional nine patients services. An additional nine patients reported crack cocaine or other stimulant reported crack cocaine or other stimulant dependence and would potentially qualify dependence and would potentially qualify for brief intervention or referral to stimu-for brief intervention or referral to stimulant clinics (if available). Although signifi-lant clinics (if available). Although significant additional numbers were cannabis-cant additional numbers were cannabisdependent, these patients are unlikely to dependent, these patients are unlikely to meet referral criteria applied by routinely meet referral criteria applied by routinely available drug services. (No drug service available drug services. (No drug service patient was dependent solely on cannabis patient was dependent solely on cannabis in our sample.) The potential for referral in our sample.) The potential for referral to alcohol services appears to be greater, to alcohol services appears to be greater, given that almost a tenth of patients given that almost a tenth of patients ( (n n¼26) reported severe alcohol misuse (i.e. 26) reported severe alcohol misuse (i.e. AUDIT score AUDIT score 4 415; Table 3 ). for CMHT referral (see Table 3 ).
Identification and management Identification and management of comorbidity of comorbidity
We compared comorbidity reported by care We compared comorbidity reported by care coordinators and keyworkers with the coordinators and keyworkers with the 3 0 8 3 0 8 NPV, negative predictive value; PPV, positive predictive value. NPV, negative predictive value; PPV, positive predictive value. 1. There was no self-reported use in this sample of the following substances: solvents, gamma-hydroxybutyrate, lysergic acid diethylamide,'magic mushrooms' (psilocybin), steroids or 1. There was no self-reported use in this sample of the following substances: solvents, gamma-hydroxybutyrate, lysergic acid diethylamide,'magic mushrooms' (psilocybin), steroids or anabolic steroids, methylphenidate, khat, ketamine, dextromoramide or buprenorphine. However, this was not verifiable by the hair or urine analysis available.Use of amyl nitrite was anabolic steroids, methylphenidate, khat, ketamine, dextromoramide or buprenorphine. However, this was not verifiable by the hair or urine analysis available.Use of amyl nitrite was reported in one case but was also not verifiable by the available hair or urine analysis. reported in one case but was also not verifiable by the available hair or urine analysis. 2. Cannabis and dipipanone are only detectable in urine. Hence, the presence of these drugs was not assessed in one case where a patient provided a hair sample but refused to 2. Cannabis and dipipanone are only detectable in urine. Hence, the presence of these drugs was not assessed in one case where a patient provided a hair sample but refused to provide urine. provide urine.
3. This patient reported using »5 worth of cannabis (type/grade unknown) 2 days a week over the month prior to testing. This was a lower level of consumption than all the other 3. This patient reported using »5 worth of cannabis (type/grade unknown) 2 days a week over the month prior to testing.This was a lower level of consumption than all the other patients who tested positive. However, the reported level of consumption should have been sufficient for the metabolite to be detectable in the urine. patients who tested positive. However, the reported level of consumption should have been sufficient for the metabolite to be detectable in the urine. 4. Patients all reported use 1 day per week over the month prior to testing, consuming one to four ecstasy tablets. In one case a hair sample was not available for analysis. Ecstasy is 4. Patients all reported use 1 day per week over the month prior to testing, consuming one to four ecstasy tablets. In one case a hair sample was not available for analysis. Ecstasy is only detected in urine for1^2 days, so the negative result might well be because the urine sample was not obtained soo enough after ingestion.This would be a likely explanation if use only detected in urine for1^2 days, so the negative result might well be because the urine sample was not obtained soo enough after ingestion.This would be a likely explanation if use were recreational at weekends. Hair samples were available in the other two cases; these patients tested positive for cocaine and amphetamine respectively, so it is likely that ecstasy were recreational at weekends. Hair samples were available in the other two cases; these patients tested positive for cocaine and amphetamine respectively, so it is likely that ecstasy would have been detected if present. would have been detected if present. 5. This patient did not report use of dihydrocodeine at any time, but did report current use of temazepam and tested positive for this. It is possible that the positive dihydrocodeine 5. This patient did not report use of dihydrocodeine at any time, but did report current use of temazepam and tested positive for this. It is possible that the positive dihydrocodeine result detected use of prescribed pain relief medication. result detected use of prescribed pain relief medication. 6. Patients were asked to report 'misuse' of sedatives or transquillisers; prescribed use was not recorded. Hence, we cannot exclude the possibility that detected use was prescribed. 6. Patients were asked to report 'misuse' of sedatives or transquillisers; prescribed use was not recorded. Hence, we cannot exclude the possibility that detected use was prescribed. Note: We compared any reported illicit or non-prescribed drug use in the preceding month with the hair and urine analysis results; analysing the centimetre of hair closest to the scalp Note: We compared any reported illicit or non-prescribed drug use in the preceding month with the hair and urine analysis results; analysing the centimetre of hair closest to the scalp (i.e. growth expected over a month in average adult) is a reliable test of whether a drug has been used in the past month. (i.e. growth expected over a month in average adult) is a reliable test of whether a drug has been used in the past month.
relevant reference assessments obtained at relevant reference assessments obtained at interview. Patients without comorbidity interview. Patients without comorbidity were generally correctly identified as such were generally correctly identified as such by services (specificity by services (specificity 4 490%). However, 90%). However, substance misuse service patients with psy-substance misuse service patients with psychiatric disorders and CMHT patients chiatric disorders and CMHT patients reporting harmful alcohol use were mostly reporting harmful alcohol use were mostly unrecognised (sensitivity 20-38%). Only unrecognised (sensitivity 20-38%). Only in relation to CMHT patients reporting in relation to CMHT patients reporting (any) drug use did care coordinators (any) drug use did care coordinators achieve moderately good sensitivity (60%) achieve moderately good sensitivity (60%) ( Table 5) . (Table 5 ).
Small minorities of CMHT patients Small minorities of CMHT patients with comorbidity had received alcohol-or with comorbidity had received alcohol-or drug-related interventions in the month drug-related interventions in the month prior to assessment -15 of 72 reporting prior to assessment -15 of 72 reporting harmful alcohol use (21%) and 14 of 84 harmful alcohol use (21%) and 14 of 84 reporting problem drug use (17%) -reporting problem drug use (17%)mostly counselling provided through the mostly counselling provided through the CMHT. Seven patients had contact with CMHT. Seven patients had contact with specialist drug or alcohol services. More specialist drug or alcohol services. More patients with high referral potential (as patients with high referral potential (as defined above) received substance misuse defined above) received substance misuse interventions, but interventions were more interventions, but interventions were more likely to be provided to patients with likely to be provided to patients with either high or low referral potential if a either high or low referral potential if a care coordinator identified the comor-care coordinator identified the comorbidity problem. For example, 11 of 14 bidity problem. For example, 11 of 14 CMHT patients with identified severe CMHT patients with identified severe alcohol problems received interventions alcohol problems received interventions compared with 1 of the 12 whose severe compared with 1 of the 12 whose severe problems were undetected. problems were undetected.
More than a fifth of drug and alcohol More than a fifth of drug and alcohol services patients with comorbidity (48 of services patients with comorbidity (48 of 214) had contact with psychiatric services, 214) had contact with psychiatric services, of whom 26 (12%) were allocated to of whom 26 (12%) were allocated to CMHT management during the previous CMHT management during the previous month. Patients with 'high' referral poten-month. Patients with 'high' referral potential were significantly more likely to have tial were significantly more likely to have contact with psychiatric services than those contact with psychiatric services than those rated 'low' (35/59, 59% rated 'low' (35/59, 59% v. v. 13/155, 8%; 13/155, 8%; w w 2 2 ¼60.8, d.f. 60.8, d.f.¼1, 1, P P5 50.001). Some patients 0.001). Some patients with comorbidity reported consultations with comorbidity reported consultations with a psychiatrist in the substance misuse with a psychiatrist in the substance misuse service ( service (n n¼41, 19%) or with a general 41, 19%) or with a general practitioner ( practitioner (n n¼57, 27%) about their 57, 27%) about their mental health problems, but 32% mental health problems, but 32% ( (n n¼68) received no intervention. Most of 68) received no intervention. Most of the latter were patients with undetected, the latter were patients with undetected, 'low referral potential' problems (48/68, 'low referral potential' problems (48/68, 71%). 71%).
DISCUSSION DISCUSSION
Study limitations Study limitations
Certain study limitations should be Certain study limitations should be acknowledged. First, we assessed co-acknowledged. First, we assessed comorbidity within current treatment popula-morbidity within current treatment populations, which tend to include more complex tions, which tend to include more complex cases; therefore, findings are not general-cases; therefore, findings are not generalisable to the same diagnostically defined isable to the same diagnostically defined groups within the general population. groups within the general population. Second, given our sample sizes, some preva-Second, given our sample sizes, some prevalence estimates lack precision. Third, the lence estimates lack precision. Third, the study compares the prevalence of co-study compares the prevalence of comorbidity in samples drawn from two morbidity in samples drawn from two urban centres in London and from Notting-urban centres in London and from Nottingham and Sheffield. Although the study ham and Sheffield. Although the study represents an advance on previous single-represents an advance on previous singlecentre studies and highlights the potential centre studies and highlights the potential for variability in prevalence, we need to for variability in prevalence, we need to exercise caution in our interpretation of exercise caution in our interpretation of these findings. We make no claim that these findings. We make no claim that Nottingham and Sheffield are representa-Nottingham and Sheffield are representative of urban areas outside London. tive of urban areas outside London. Similarly, it is important to note that the Similarly, it is important to note that the London centres were both inner-city ones London centres were both inner-city ones and not representative of London as a and not representative of London as a whole. People in inner London with severe whole. People in inner London with severe mental illness have rates of geographical mental illness have rates of geographical mobility that are twice as high as those mobility that are twice as high as those for outer London. This may help account for outer London. This may help account for higher psychiatric morbidity (Lamont for higher psychiatric morbidity (Lamont et al et al, 2000) . Further investigation in more , 2000) . Further investigation in more regions would be required before any regions would be required before any definitive picture emerges about regional definitive picture emerges about regional variation in prevalence. variation in prevalence.
Despite these limitations, the study Despite these limitations, the study provides strong evidence that comorbidity provides strong evidence that comorbidity 3 0 9 3 0 9 1. High potential for referral to adult psychiatric services was defined as the presence of either psychosis or severe depression plus at least one of the following vulnerability criteria: 1. High potential for referral to adult psychiatric services was defined as the presence of either psychosis or severe depression plus at least one of the following vulnerability criteria: previous psychiatric admission, recorded history of suicide attempt, self-harm or serious self-neglect. previous psychiatric admission, recorded history of suicide attempt, self-harm or serious self-neglect. (4) Ecstasy (3,4-methylenedioxymethamphetamine) Ecstasy (3,4-methylenedioxymethamphetamine) 6 (5) 6 (5) 5 ( Patients were asked specifically about methadone, dextromoramide, dihydrocodeine tartrate, dipipanone hydrochloride and buprenorphine. 3. Aggregation of subgroup exceeds group totals owing to patients having more than one disorder. 3. Aggregation of subgroup exceeds group totals owing to patients having more than one disorder.
is highly prevalent in CMHT, drug is highly prevalent in CMHT, drug and alcohol treatment populations. Our and alcohol treatment populations. Our findings relating to the profile and manage-findings relating to the profile and management of comorbidity also have major ment of comorbidity also have major implications for service development. implications for service development.
Prevalence and pattern Prevalence and pattern of comorbidity of comorbidity
Overall, 44% of CMHT patients reported Overall, 44% of CMHT patients reported past-year problem drug use and/or harmful past-year problem drug use and/or harmful alcohol use. This is higher than previously alcohol use. This is higher than previously observed in comparable UK populations observed in comparable UK populations using similar assessment methods (33-using similar assessment methods (33-36%) and is largely accounted for by a 36%) and is largely accounted for by a higher level of drug use than previously higher level of drug use than previously reported (Menezes reported (Menezes et al et al, 1996; Wright , 1996; Wright et et al al, 2000; Duke , 2000; Duke et al et al, 2001) . Hair and urine , 2001) . Hair and urine analysis revealed no significant covert drug analysis revealed no significant covert drug use and suggested that these self-reported use and suggested that these self-reported drug use data provide a reliable and valid drug use data provide a reliable and valid basis for prevalence estimation. Given that basis for prevalence estimation. Given that consent for obtaining hair and urine consent for obtaining hair and urine samples was separate from and subsequent samples was separate from and subsequent to interviews, we can exclude the possibility to interviews, we can exclude the possibility that patients were more accurate in report-that patients were more accurate in reporting drug use because they knew they were ing drug use because they knew they were to be tested. The prevalence of harmful to be tested. The prevalence of harmful alcohol use among CMHT patients (26%) alcohol use among CMHT patients (26%) is consistent with previous estimates (20-is consistent with previous estimates (20-32%) using self-reported measures 32%) using self-reported measures (Menezes (Menezes et al et al, 1996; Wright , 1996; Wright et al et al, 2000; , 2000; Duke Duke et al et al, 2001 ). , 2001 . Findings in relation to the validity of Findings in relation to the validity of prevalence estimates of comorbidity prevalence estimates of comorbidity reported by keyworkers at the case-load reported by keyworkers at the case-load census have important implications for census have important implications for service development, the interpretation of service development, the interpretation of previously published research and the previously published research and the design of future studies. Studies that have design of future studies. Studies that have estimated prevalence on the basis of assess-estimated prevalence on the basis of assessments provided by keyworker informants ments provided by keyworker informants may underestimate prevalence (e.g. may underestimate prevalence (e.g. Graham Graham et al et al, 2001; Weaver , 2001; Weaver et al et al, 2001) . , 2001). Our findings confirm that comorbidity Our findings confirm that comorbidity of severe mental illness and substance of severe mental illness and substance misuse is highly prevalent in urban UK misuse is highly prevalent in urban UK mental health settings. However, findings mental health settings. However, findings in relation to the level of problem drug in relation to the level of problem drug use are even more striking when the differ-use are even more striking when the differences between centres are considered. In the ences between centres are considered. In the London centres, 42% of CMHT patients London centres, 42% of CMHT patients reported problem drug use and 25% were reported problem drug use and 25% were assessed as drug dependent. Overall, more assessed as drug dependent. Overall, more than half of London CMHT patients than half of London CMHT patients reported substance misuse problems in the reported substance misuse problems in the past year. We stress the importance of past year. We stress the importance of cautious interpretation of these findings, cautious interpretation of these findings, but nevertheless this does appear to confirm but nevertheless this does appear to confirm the view that patients with such comorbid-the view that patients with such comorbidity may represent the core client group of ity may represent the core client group of CMHTs in certain inner-city areas, where CMHTs in certain inner-city areas, where the prevalence may be dramatically high the prevalence may be dramatically high (Banerjee (Banerjee et al et al, 2002 (Banerjee et al et al, ). , 2002 . Large majorities of patients treated for Large majorities of patients treated for drug and alcohol misuse experience psychi-drug and alcohol misuse experience psychiatric disorder, although there was no atric disorder, although there was no suggestion that these rates differed signifi-suggestion that these rates differed significantly between centres in our study. Our cantly between centres in our study. Our estimates for the prevalence of severe estimates for the prevalence of severe depression and personality disorder are depression and personality disorder are consistent with other studies of comparable consistent with other studies of comparable populations (Regier populations (Regier et al et al, 1990; Verheul, , 1990; Verheul, 2001) . However, the prevalence of psycho-2001). However, the prevalence of psychosis (drug service patients 8%, alcohol sis (drug service patients 8%, alcohol service patients 19%) was significantly service patients 19%) was significantly higher than previously reported (Regier higher than previously reported (Regier et et al al, 1990) and was 10 times (drug) and 24 , 1990) and was 10 times (drug) and 24 times (alcohol) the prevalence rate for psy-times (alcohol) the prevalence rate for psychosis in the urban UK population (0.8%; chosis in the urban UK population (0.8%; Jenkins Jenkins et al et al, 1998) . , 1998).
Implications for management Implications for management
In each population studied, comorbid In each population studied, comorbid presentations were heterogeneous. Re-presentations were heterogeneous. Responding to the level and range of need will sponding to the level and range of need will be challenging given associated clinical be challenging given associated clinical management problems (Scott management problems (Scott et al et al, 1998; , 1998;  311 311 Comorbidity cannot be adequately managed by cross-referral between psychiatric and substance misuse services as currently configured and resourced. A new and substance misuse services as currently configured and resourced. A new approach is needed to enable psychiatric and substance misuse services to offer approach is needed to enable psychiatric and substance misuse services to offer evidence-based treatment of comorbid conditions to a much higher proportion of evidence-based treatment of comorbid conditions to a much higher proportion of their patients. their patients.
LIMITATIONS LIMITATIONS
& & Because comorbidity was assessed within treatment populations, findings are not Because comorbidity was assessed within treatment populations, findings are not generalisable to the same diagnostically defined groups within the general population. generalisable to the same diagnostically defined groups within the general population.
& & Some prevalence estimates lack precision owing to small sample sizes.
Some prevalence estimates lack precision owing to small sample sizes.
& & We found significant differences in the prevalence of drug use among psychiatric We found significant differences in the prevalence of drug use among psychiatric patients in different centres, but evidence from more centres is required before firm patients in different centres, but evidence from more centres is required before firm conclusions about regional differences in prevalence are made. conclusions about regional differences in prevalence are made. 
Analysis of urine for drugs of abuse using mixed-mode Analysis of urine for drugs of abuse using mixed-mode solid-phase extraction and gas chromatography^mass solid-phase extraction and gas chromatography^mass spectrometry. spectrometry. Annals of Clinical Biochemistry Annals of Clinical Biochemistry, , 37 37, , 690^700. 690^700. Wright, S., Gournay, K., Glorney, E., Wright, S., Gournay, K., Glorney, E., et al et al (2000) (2000) Dual Dual diagnosis in the suburbs: prevalence, need and in-patient diagnosis in the suburbs: prevalence, need and in-patient service use. service use. Social Psychiatry and Psychiatric Epidemiology Social Psychiatry and Psychiatric Epidemiology, , 35 35, 297^304. , 297^304.
